Inactive Instrument

Company Chromadex Corp OTC Bulletin Board

Equities

CDXC

US1710771007

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Chromadex Corp

Business Summary

Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Sales per Business

USD in Million2022Weight2023Weight Delta
Consumer Products
83.2 %
60 83.4 % 70 83.2 % +15.67%
Ingredients
13.3 %
9 12.1 % 11 13.3 % +27.48%
Analytical Reference Standards and Services
3.5 %
3 4.4 % 3 3.5 % -9.33%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
70.1 %
50 69.8 % 59 70.1 % +16.50%
International
29.9 %
22 30.2 % 25 29.9 % +14.68%

Managers

Managers TitleAgeSince
Chief Executive Officer 64 15-07-08
Founder 55 98-12-31
Director of Finance/CFO 44 -
Human Resources Officer - -
Corporate Officer/Principal - -
Sales & Marketing - -
General Counsel - -
General Counsel - 20-01-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 17-03-26
Director/Board Member 49 22-08-08
Founder 55 98-12-31
Chief Executive Officer 64 15-07-08
Director/Board Member 53 22-04-14
Director/Board Member 48 17-08-17
Director/Board Member 52 21-12-12
Director/Board Member 63 22-04-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 75,523,785 44,506,952 ( 58.93 %) 0 58.93 %

Shareholders

NameEquities%Valuation
Champion River Ventures Ltd.
15.15 %
11,408,715 15.15 % 40 M $
Pioneer Step Holdings Ltd.
10.47 %
7,885,641 10.47 % 27 M $
3,816,794 5.068 % 13 M $
Li Family
4.605 %
3,467,778 4.605 % 12 M $
Vanguard Global Advisers LLC
4.047 %
3,048,119 4.047 % 11 M $
Tieton Capital Management LLC
3.869 %
2,913,675 3.869 % 10 M $
2,306,391 3.063 % 8 M $
1,580,061 2.098 % 5 M $
ICONIQ Capital LLC
1.721 %
1,296,354 1.721 % 5 M $
BlackRock Institutional Trust Co. NA
1.189 %
895,644 1.189 % 3 M $

Company contact information

Chromadex Corp.

10900 Wilshire Boulevard Suite 600

90024, Los Angeles

+310 388 6706

http://www.chromadex.com
address Chromadex Corp(CDXC)